...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and Biological Evaluation of 2,3,5-Substituted [1,2,4]Thiadiazoles as Allosteric Modulators of Adenosine Receptors
【24h】

Synthesis and Biological Evaluation of 2,3,5-Substituted [1,2,4]Thiadiazoles as Allosteric Modulators of Adenosine Receptors

机译:2,3,5-取代的[1,2,4]噻二唑作为腺苷受体的变构调节剂的合成及生物学评价

获取原文
获取原文并翻译 | 示例

摘要

A number of 2,3,5-substituted [1,2,4]thiadiazole analogues of SCH-202676 (N-(2,3-diphenyl[1,2,4]thiadiazole-5(~2H)-ylidene)methanamine, 7a) were synthesized and tested as potential allosteric modulators of adenosine receptors. All compounds were capable of displacing the binding of the radiolabeled agonist [3H]CCPA to human A1 adenosine receptors, whereas modest and varying effects were observed on the binding of [~3H]DPCPX, a radiolabeled antagonist for this receptor subtype. Four compounds, 7a (SCH-202676), 7k (LUF5792), 7l (LUF5794), and 8e (LUF5789), were selected for more detailed characterization. They all proved allosteric inhibitors of agonist binding, with 7k being most potent, whereas their effects on antagonist binding were more ambiguous. Subsequently, experiments were done on human adenosine A2A and A3 receptors. Compounds 7a and 7l displayed peculiar displacement characteristics of both radiolabeled agonist and antagonist binding to A_(2A) receptors, whereas 7a showed some activity on A_3 receptors.
机译:SCH-202676(N-(2,3-二苯基[1,2,4]噻二唑-5(〜2H)-亚烷基)甲胺的许多2,3,5-取代[1,2,4]噻二唑类似物,7a)被合成并测试为腺苷受体的潜在变构调节剂。所有化合物均能够取代放射性标记的激动剂[3H] CCPA与人A1腺苷受体的结合,而对[〜3H] DPCPX的结合则观察到适度且变化的作用,后者是该受体亚型的放射性标记拮抗剂。选择了四种化合物7a(SCH-202676),7k(LUF5792),7l(LUF5794)和8e(LUF5789)进行更详细的表征。他们都证明了激动剂结合的变构抑制剂,最有效的是7k,而它们对拮抗剂结合的作用则比较模糊。随后,对人腺苷A2A和A3受体进行了实验。化合物7a和7l显示出放射性标记的激动剂和拮抗剂与A_(2A)受体结合的独特位移特征,而化合物7a显示出对A_3受体的某些活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号